you can't create a new drug by running a model on a laptop. You can't serve a customer support bot running on a laptop. You can't generate video in bulk for many users on a laptop. So there is still a case for paying others for inference.
Does it justify the valuations? No idea, but some major use cases are still there. That's why they are rushing to implement, OpenAI creating a "deployment company", Anthropic having some pharma rumors, etc.
I think GP was asking specifically about the use case for closed models.
Or, the company itself can rent the GPU and host the model of their choice on it.
> But they would have to keep up with how good the private models are.
Why? The whole point of the thread is that the marginal gains of using private models is a fraction of the additional cost of using those private models.
IOW, if you really need that improvement over the open models, you can go ahead and pay it. What we are seeing though is that the improvement in general is barely noticeable but the cost is 4x as much.